Diabetes
From the Journals
Fair access crucial for new diabetes/kidney disease drugs, say guidelines
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and...
From the Journals
PPI use in type 2 diabetes links with cardiovascular events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more...
Feature
Latest steps toward reducing U.S. insulin cost begin in 2023
Beneficiaries who take insulin via pen or syringe, covered under Medicare part D, fall under the $35/month co-pay cap.
Latest News
Mediterranean diet linked with fewer pregnancy complications
Women who closely followed the diet heavy in fresh fruits and vegetables, fish, and olive oil around the time of conception had fewer adverse...
From the Journals
Diabetes surge expected in young people
It is expected that as many as 526,000 people younger than 20 years in the United States will have diabetes by 2060.
News
FDA approves Wegovy (semaglutide) for obesity in teens 12 and up
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.
Conference Coverage
Dubious diagnosis: Is there a better way to define ‘prediabetes’?
There have been major increases in prediabetes in the United States and globally over the past 2 decades.
From the Journals
Fitbit figures: More steps per day cut type 2 diabetes risk
The protective effect of daily step count on type 2 diabetes risk remained after adjusting for smoking and sedentary time.
Latest News
AI takes root in primary care. First stop: Diabetic retinopathy
This technology “can potentially help us in decreasing disparities in care and focusing our efforts on patients with the most severe diseases.”
Latest News
Not all children with type 2 diabetes have obesity
Normal-weight children with other risk factors should be screened.
From the Journals
Intermittent fasting can lead to type 2 diabetes remission
Intermittent fasting could be a paradigm shift in type 2 diabetes management, allowing patients to stop taking glucose-lowering medication.